This situation basically arises from the fact that in vitro or physiological mapping of
the molecule is a prerequisite for DDI.
One other approach aiding SBDD is de novo method, which means “from the
beginning.” Active site of drug targets when characterized from a structural point of
view will shed light on its binding features. This information of active site composition
and the orientation of various amino acids at the binding site can be used to design
ligands specific to that particular target. Computational tools that can analyze protein
active site and suggest potential compounds are extensively used for de novo design
methods. Many promising approaches with the goal of ligand design have been
reported.
Gane and Dean [169] reported that various de novo methods, especially whole
molecule methods like docking, have become integrated within disciplines that
include chemistry, pharmacology, molecular biology, and computer modeling.
Electrostatic and solvation terms critical for evaluating correct binding energies are
difficult and slow to calculate. Advances in algorithm sophistication are providing
better approximations for these parameters.
Advancement in different concepts and parameters that are crucial in SBDD is to be
employed to improve the outcome of ligand search. For instance, SBDD techniques
range from simple docking process to proteins considered to be rigid where complex
calculations involving the water mediator interactions are involved. Flexible docking
approach, first introduced by Totrov and Abagyan [170], and the use of water
molecules in docking calculation, introduced by Lengauer [171], are two of the
several milestones achieved in structure-based drug designing approaches. There are
wide varieties of docking programs available for users in both public and private. One
of the advancements is found in combining the aspects of protein flexibility and
displaced water molecule in a docking processor, named FITTED for better binding
calculations. The success of the program can be seen in the identification of molecules
in various drug discovery programs and collaborations [172].
Complementarity and ranking are calculated by a scoring function that is either
based on empirically fit descriptors [44, 54, 173–175], knowledge-based potential
functions [61, 62, 176], or physics-based terms [51, 93, 177–179]. Physics-based
scoring functions borrow force field derived terms, such as van der Waals
(vdW) and electrostatics, to calculate the protein–ligand interaction energy [180,
181]. A new scoring function was introduced by Micheal et al., where scoring term
is dependent on context-dependent ligand desolvation. Here, every ligand atom’s
Born radii is related to fractional desolvation. This fraction is employed in scaling
an atom-by-atom decomposition of the full transfer free energy [182]. This is scored
across the grid, and the new method improves docking performance. This method is
effective in discriminating ligands and that of other charged molecules compared to
others. With the advantage of calculating the context-dependent ligand desolvation
beforehand, the scoring function can enhance the docking consistency without
costing much time. Such advancements in different aspects of programming and
analysis, both in experimental and also theoretical understanding, will greatly
influence the outcome of our quest in identification of drug molecules in subsiding
various human ailments and infections.
290
D. Velmurugan et al.
the molecule is a prerequisite for DDI.
One other approach aiding SBDD is de novo method, which means “from the
beginning.” Active site of drug targets when characterized from a structural point of
view will shed light on its binding features. This information of active site composition
and the orientation of various amino acids at the binding site can be used to design
ligands specific to that particular target. Computational tools that can analyze protein
active site and suggest potential compounds are extensively used for de novo design
methods. Many promising approaches with the goal of ligand design have been
reported.
Gane and Dean [169] reported that various de novo methods, especially whole
molecule methods like docking, have become integrated within disciplines that
include chemistry, pharmacology, molecular biology, and computer modeling.
Electrostatic and solvation terms critical for evaluating correct binding energies are
difficult and slow to calculate. Advances in algorithm sophistication are providing
better approximations for these parameters.
Advancement in different concepts and parameters that are crucial in SBDD is to be
employed to improve the outcome of ligand search. For instance, SBDD techniques
range from simple docking process to proteins considered to be rigid where complex
calculations involving the water mediator interactions are involved. Flexible docking
approach, first introduced by Totrov and Abagyan [170], and the use of water
molecules in docking calculation, introduced by Lengauer [171], are two of the
several milestones achieved in structure-based drug designing approaches. There are
wide varieties of docking programs available for users in both public and private. One
of the advancements is found in combining the aspects of protein flexibility and
displaced water molecule in a docking processor, named FITTED for better binding
calculations. The success of the program can be seen in the identification of molecules
in various drug discovery programs and collaborations [172].
Complementarity and ranking are calculated by a scoring function that is either
based on empirically fit descriptors [44, 54, 173–175], knowledge-based potential
functions [61, 62, 176], or physics-based terms [51, 93, 177–179]. Physics-based
scoring functions borrow force field derived terms, such as van der Waals
(vdW) and electrostatics, to calculate the protein–ligand interaction energy [180,
181]. A new scoring function was introduced by Micheal et al., where scoring term
is dependent on context-dependent ligand desolvation. Here, every ligand atom’s
Born radii is related to fractional desolvation. This fraction is employed in scaling
an atom-by-atom decomposition of the full transfer free energy [182]. This is scored
across the grid, and the new method improves docking performance. This method is
effective in discriminating ligands and that of other charged molecules compared to
others. With the advantage of calculating the context-dependent ligand desolvation
beforehand, the scoring function can enhance the docking consistency without
costing much time. Such advancements in different aspects of programming and
analysis, both in experimental and also theoretical understanding, will greatly
influence the outcome of our quest in identification of drug molecules in subsiding
various human ailments and infections.
290
D. Velmurugan et al.